TNF-α has been recently reported to be a potent mediator of ROS production [50], thus leading to damage of hepatocytes in patients with Non-alcoholic Steatohepatitis, where an increase of EVOLV-6 has also been described [51]. Here, TNF is linked to metabolic dysfunction-associated steatohepatitis.